NO20011309L - Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister - Google Patents

Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister

Info

Publication number: NO20011309L
Authority: NO; Norway
Prior art keywords: benzotieno; pyridines; alfa; antagonists
Prior art date: 1998-10-06

Application number

NO20011309A

Other languages

English (en)

Other versions

NO20011309D0 (no

Inventor

Ludo Edmond Josephine Kennis

Serge Maria Aloysius Pieters

Francois Paul Bischoff

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-06

Filing date

2001-03-15

Publication date

2001-03-15

2001-03-15 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2001-03-15 Publication of NO20011309L publication Critical patent/NO20011309L/no

2001-03-15 Publication of NO20011309D0 publication Critical patent/NO20011309D0/no

Links

239000005557 antagonist Substances 0.000 title 1
150000003222 pyridines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Obesity (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO20011309A 1998-10-06 2001-03-15 Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister NO20011309D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203363		1998-10-06
PCT/EP1999/007418 WO2000020422A1 (en)	1998-10-06	1999-10-01	BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS

Publications (2)

Publication Number	Publication Date
NO20011309L true NO20011309L (no)	2001-03-15
NO20011309D0 NO20011309D0 (no)	2001-03-15

Family

ID=8234188

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20011309A NO20011309D0 (no)	1998-10-06	2001-03-15	Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister

Country Status (27)

Country	Link
US (2)	US6426350B1 (no)
EP (1)	EP1117667B1 (no)
JP (1)	JP4580555B2 (no)
KR (1)	KR20010071828A (no)
CN (1)	CN1158287C (no)
AR (1)	AR023678A1 (no)
AT (1)	ATE363485T1 (no)
AU (1)	AU760226B2 (no)
BG (1)	BG64625B1 (no)
BR (1)	BR9913110A (no)
CA (1)	CA2346084C (no)
CZ (1)	CZ20011103A3 (no)
DE (1)	DE69936219T2 (no)
EE (1)	EE04835B1 (no)
ES (1)	ES2288025T3 (no)
HU (1)	HUP0103612A3 (no)
ID (1)	ID28280A (no)
IL (2)	IL142442A0 (no)
NO (1)	NO20011309D0 (no)
NZ (1)	NZ509911A (no)
PL (1)	PL347184A1 (no)
RU (1)	RU2222542C2 (no)
SK (1)	SK4312001A3 (no)
TR (1)	TR200100954T2 (no)
TW (1)	TWI251595B (no)
UA (1)	UA70334C2 (no)
WO (1)	WO2000020422A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050176633A1 (en) *	2002-03-08	2005-08-11	Axel Ullrich	Use of egfr transactivation inhibitors in human cancer
US20050203100A1 (en) *	2002-04-03	2005-09-15	Jukka Sallinen	Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
JP4816453B2 (ja)	2004-04-12	2011-11-16	大正製薬株式会社	環状アミン化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3752820A (en) *	1972-03-20	1973-08-14	Colgate Palmolive Co	Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) *	1984-09-27	1987-05-22	Synthelabo	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) *	1985-09-03	1987-08-11	Merck & Co., Inc.	Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) *	1988-04-27	1991-03-20	Glaxo Group Limited	Lactam derivatives
US5100891A (en) *	1991-01-18	1992-03-31	Hoechst-Roussel Pharmaceuticals Inc.	Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB9106179D0 (en) *	1991-03-22	1991-05-08	Sandoz Ltd	Improvements in or relating to organic compounds
ES2204932T3 (es) *	1994-09-12	2004-05-01	Eli Lilly And Company Limited	Moduladores serotonergicos.
JP3274579B2 (ja) *	1995-01-12	2002-04-15	住友製薬株式会社	脳血管障害に伴う精神症候治療剤
UA52681C2 (uk)	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

1999
- 1999-01-10 UA UA2001031998A patent/UA70334C2/uk unknown
- 1999-10-01 TR TR2001/00954T patent/TR200100954T2/xx unknown
- 1999-10-01 NZ NZ509911A patent/NZ509911A/xx unknown
- 1999-10-01 ES ES99947469T patent/ES2288025T3/es not_active Expired - Lifetime
- 1999-10-01 TW TW088116899A patent/TWI251595B/zh not_active IP Right Cessation
- 1999-10-01 SK SK431-2001A patent/SK4312001A3/sk unknown
- 1999-10-01 EP EP99947469A patent/EP1117667B1/en not_active Expired - Lifetime
- 1999-10-01 KR KR1020017000400A patent/KR20010071828A/ko not_active Ceased
- 1999-10-01 JP JP2000574534A patent/JP4580555B2/ja not_active Expired - Fee Related
- 1999-10-01 EE EEP200100206A patent/EE04835B1/xx not_active IP Right Cessation
- 1999-10-01 CN CNB998116777A patent/CN1158287C/zh not_active Expired - Fee Related
- 1999-10-01 WO PCT/EP1999/007418 patent/WO2000020422A1/en not_active Ceased
- 1999-10-01 AU AU60899/99A patent/AU760226B2/en not_active Ceased
- 1999-10-01 CZ CZ20011103A patent/CZ20011103A3/cs unknown
- 1999-10-01 CA CA2346084A patent/CA2346084C/en not_active Expired - Fee Related
- 1999-10-01 BR BR9913110-2A patent/BR9913110A/pt not_active Application Discontinuation
- 1999-10-01 DE DE69936219T patent/DE69936219T2/de not_active Expired - Lifetime
- 1999-10-01 PL PL99347184A patent/PL347184A1/xx not_active Application Discontinuation
- 1999-10-01 ID IDW20010781A patent/ID28280A/id unknown
- 1999-10-01 HU HU0103612A patent/HUP0103612A3/hu unknown
- 1999-10-01 US US09/806,432 patent/US6426350B1/en not_active Expired - Lifetime
- 1999-10-01 AT AT99947469T patent/ATE363485T1/de not_active IP Right Cessation
- 1999-10-01 RU RU2001111753/04A patent/RU2222542C2/ru not_active IP Right Cessation
- 1999-10-01 IL IL14244299A patent/IL142442A0/xx active IP Right Grant
- 1999-10-05 AR ARP990105039A patent/AR023678A1/es active IP Right Grant
2001
- 2001-03-12 BG BG105331A patent/BG64625B1/bg unknown
- 2001-03-15 NO NO20011309A patent/NO20011309D0/no not_active Application Discontinuation
- 2001-04-04 IL IL142442A patent/IL142442A/en not_active IP Right Cessation
2002
- 2002-04-16 US US10/123,338 patent/US6774129B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
TWI251595B (en)	2006-03-21
SK4312001A3 (en)	2001-12-03
TR200100954T2 (tr)	2001-12-21
IL142442A0 (en)	2002-03-10
BG64625B1 (bg)	2005-09-30
US6426350B1 (en)	2002-07-30
ID28280A (id)	2001-05-10
EE04835B1 (et)	2007-06-15
HK1039113A1 (en)	2002-04-12
AU760226B2 (en)	2003-05-08
EP1117667B1 (en)	2007-05-30
DE69936219D1 (de)	2007-07-12
EP1117667A1 (en)	2001-07-25
DE69936219T2 (de)	2008-02-07
HUP0103612A2 (hu)	2002-01-28
CA2346084A1 (en)	2000-04-13
IL142442A (en)	2006-10-05
US6774129B2 (en)	2004-08-10
BR9913110A (pt)	2001-05-08
JP4580555B2 (ja)	2010-11-17
JP2002526546A (ja)	2002-08-20
PL347184A1 (en)	2002-03-25
UA70334C2 (en)	2004-10-15
NO20011309D0 (no)	2001-03-15
CA2346084C (en)	2010-01-26
RU2222542C2 (ru)	2004-01-27
ES2288025T3 (es)	2007-12-16
HUP0103612A3 (en)	2003-03-28
KR20010071828A (ko)	2001-07-31
ATE363485T1 (de)	2007-06-15
WO2000020422A1 (en)	2000-04-13
US20020169178A1 (en)	2002-11-14
NZ509911A (en)	2002-09-27
CZ20011103A3 (cs)	2001-12-12
AU6089999A (en)	2000-04-26
CN1321159A (zh)	2001-11-07
BG105331A (en)	2001-11-30
CN1158287C (zh)	2004-07-21
EE200100206A (et)	2002-06-17
AR023678A1 (es)	2002-09-04

Legal Events

Date	Code	Title	Description
2008-05-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
IS5722A (is)	2000-11-21	Pýróló [2,3-dl]pírimídín efnasambönd
DE69933287D1 (de)	2006-11-02	12,13-modifizierte epothilon-derivate
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
ID26698A (id)	2001-02-01	SENYAWA-SENYAWA PIROLO [2,3-d] PIRIMIDINA
DK1379511T3 (da)	2005-11-07	Dihydro-benzo[b][1,4]diazepin-2-on-derivater som mGLuR2-antagonister II
DE60019577D1 (de)	2005-05-25	4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
ATE312819T1 (de)	2005-12-15	4,4-biarylpiperidinederivate mit opioid-receptor- wirkung
NO20034496D0 (no)	2003-10-08	Dihydro-benzo[b][1,4]diazepin-2-on-derivater som MGLUR2- antagonister I
DE50107988D1 (de)	2005-12-15	Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
EE200000428A (et)	2001-12-17	VLA-4 antagonistid
ID22131A (id)	1999-09-09	Turunan-turunan 1,2,3,4-tetrahidro-benzofuran [3,2-c] piridin
NO20003825D0 (no)	2000-07-26	1,3,4 - oxadiazolonderivater
ATE204279T1 (de)	2001-09-15	Diaza-spiro(3,5)nonan-derivate
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
ID27845A (id)	2001-04-26	Turunan tetrahidrokuilina sebagai antagonis glisilina
DK1149106T3 (da)	2003-07-14	4,5-azolo-oxindoler
DK1075471T3 (da)	2005-01-17	Idolylderivater som serotonerge midler
NO20011270D0 (no)	2001-03-13	Tricykliske <delta>3-piperidiner som <alfa>2-antagonister
ID27686A (id)	2001-04-19	Turunan 3-(2-okso-[1,3]bipirolidinil-3-ildenametil)-sefem
NO20011309D0 (no)	2001-03-15	Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister
EP1156040A4 (en)	2002-03-20	2,4-dioxo-5-ARYLIDENIMIDO-1,3-pyrimidines
NO20002575D0 (no)	2000-05-19	Substituerte oksimer som neurokininantagonister
ID26368A (id)	2000-12-14	Turunan-turunan 2 deoksi higromisin
IS5877A (is)	2001-03-05	Ný efnablanda
DE59909590D1 (de)	2004-07-01	Azidfreie, gaserzeugende zusammensetzung